openPR Logo
Press release

Imbruvica Market Size, Share | Industry Growth Report, 2019-2025

05-23-2019 11:31 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Adroit Market Research

Imbruvica Market Size, Share | Industry Growth Report,

The Global Imbruvica Market was valued at USD 6.20 billion in 2018. Emergence of novel cancer therapies and targeted therapy for rising number of patients with lymphomas and leukemia are the prime factors for the growth of the global Imbruvica market.

Get more Information about this Report @

Targeted cancer therapies are drugs that restrain the development and spread of cancer by interfering with particularmolecules ("molecular targets") that take part in the growth, progression, and metastasis of cancer. Targeted drugs specifically attack malignant cells or precise targets, unlike traditional chemotherapy drugs, which randomly attack healthy cells as well as cancer cells. These days much attention is being given to anti-cancer targeted drugs, under development. These drugs are often the cornerstone of precision medicine, as they use genetic information to prevent, diagnose and treat diseases. Imbruvica targets Bruton's tyrosine kinase (BTK) by blocking its activity. This inhibits the communication signals within B cells, which in turn transports malignant B cells out of their nourishing environment from the lymph nodes, bone marrow and other organs.

Request Sample Pages for more Insights @

Imbruvica is approved for the treatment of Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), Waldenström's Macroglobulinemia (WM), Relapsed/Refractory Marginal Zone Lymphoma (RR MZL) and Chronic Graft-Versus-Host-Disease (cGVHD). CLL accounted for majority market share in 2018 and is expected to retain its position by 2025 with 55.9% market share. CLL is the most common blood cancer in people aged 70 and above. However, the incidence of the disease ranges from 30/100,000 in individuals aged 80 years and older.

U.S. is a major hub for Imbruvica market due to presence of prominent players, large patient pool and supportive government initiatives. It also holds patent exclusivity for Imbruvica. Smoking, exposure to certain chemicals, radiation and obesity are the foremost risk factors associated with blood cancers in the U.S. However, efforts are being undertaken to promote healthy lifestyles which will significantly drop down the incidence rates of blood cancer. Imbruvica players in the United States include Janssen Pharmaceuticals, Inc. and Pharmacyclics LLC (an AbbVie Company).

For Any Query on the Imbruvica market @
Key Segments of the Global Imbruvica Market

Application Overview, 2015-2025 (USD Million)
• Mantle Cell Lymphoma
• Chronic Lymphocytic Leukaemia
• Waldenström's Macroglobulinemia
• Relapsed/Refractory Marginal Zone Lymphoma
• Chronic Graft-Versus-Host-Disease

Regional Overview, 2015-2025 (USD Million)
• U.S
• Europe
• India
• Japan
• China
• Southeast Asia
• Central & South America

Reasons for the study
• With resistant strains of disease, genetic differences in patients and the requirement for more effective yet less damaging treatment options, modern medicine is beginning to change its approach
• The rising practice of combinational therapy
• ANDA approval for Ibrutinib
• Increasing number of targeted therapies in hematological malignancies

About us:
We are here to provide credible market intelligence with actionable insights. We believe that with the fast changing business environment and rapid turns in economic cycles, a lot is overlooked. With the aid of technology, a large amount of data is produced which is waiting to be analyzed and patterned. The insights which can be mined from such a large amount of data can enable businesses to grow at a pace of their choosing, be it long term goals or short-term goals. Being aware of the market movements allows for agility and agility is one of the highest rated characteristics of modern businesses.

Contact us:
Contact Name: Ryan Johnson
Contact Email:
Contact Phone: +1 (214) 884-6068

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Imbruvica Market Size, Share | Industry Growth Report, 2019-2025 here

News-ID: 1750590 • Views:

More Releases from Adroit Market Research

Subscription and Billing Management Market Analytical Overview and Growth Opportunities by 2031 | Adroit Market Research
Subscription and Billing Management Market Analytical Overview and Growth Opport …
A sort of software called subscription and billing management is used to speed up the payment process for companies that provide subscription services and depend on recurring payments. Subscription and billing management solutions automate the billing procedure to lower the possibility of errors, increase client satisfaction, and give companies access to comprehensive reporting tools. Businesses can customise subscription packages, automate billing, provide customer self-service options, manage subscriptions across various payment
Smart Office Solution Market Key Players, End User Demand and Analysis Growth Trends by 2032 | Adroit Market Research
Smart Office Solution Market Key Players, End User Demand and Analysis Growth Tr …
Innovative technologies called "smart office solutions" are created to optimise and enhance an office space's daily operations. They usually concentrate on automating repetitive processes, improving cooperation and communication, increasing staff productivity and workflow, and offering real-time insights into operational performance. The goal of smart office solutions is to help businesses save money and operate as efficiently as possible. They provide services that include cloud-based document management systems, CRM platforms, enterprise
Rewards and incentives Market 2023 Growing Rapidly with Modern Trends, Industry Share, Future Business Prospect by Forecast to 2032
Rewards and incentives Market 2023 Growing Rapidly with Modern Trends, Industry …
Rewards and incentives are expressions of appreciation and acknowledgement offered to people or groups to acknowledge their efforts, achievements, or performance. Rewards and incentives have the power to inspire workers, boost engagement, boost morale, and promote constructive behaviour at work. They may be given in the form of monetary awards or non-financial incentives like praise from others, promotions, extra vacation time, or other forms of remuneration. Rewards and incentives are
Open-Source Intelligence Market Report Covers Opportunities, Industry CAGR, Demand, Development Factors and forecast to 2031
Open-Source Intelligence Market Report Covers Opportunities, Industry CAGR, Dema …
The process of gathering and analysing information that is readily accessible to the public to produce intelligence that can be used to guide decisions is known as open-source intelligence (OSINT). Open-source intelligence is used to understand a company's or organization's operating environment, including its rivals, clients, suppliers, and potential threats. It is a technique for gathering intelligence that makes use of easily accessible and widely available data sources like the

All 5 Releases

More Releases for Imbruvica

Imbruvica Market Worth Observing Growth | AbbVie, Johnson and Johnson, SP Labora …
Latest added Global Imbruvica Market research study by HTF MI offers detailed product outlook and elaborates market review till 2025. The market Study is segmented by key regions that is accelerating the marketization. At present, the market is sharping its presence and some of the key players in the study are AbbVie, Johnson and Johnson & SP Laboratories etc. The study is a perfect mix of qualitative and quantitative Market
Imbruvica Market Share 2020-2025 | Johnson & Johnson Services Inc., Janssen Phar …
Advances in Clinical Trials and High Approvals to Tangibly Favor Growth Prognosis in Imbruvica Market Advances in cancer therapeutics and cancer management on the back of improved healthcare facilities, funding as well as relentless clinical trials and promising drug pipelines are likely to keep growth afloat in imbruvica market. Soaring instances and variants of cancer has been a persistent healthcare bottleneck. Drug development endeavors therefore are focusing on developing appropriate remedies
Global Imbruvica Market Analysis and Global Outlook 2020 to 2026: By Manufacture …
Imbruvica 2020 world market by key players, regions, type and application, forecast for 2026. The report contains a forecast for 2020 and ends in 2026 with a series of measures such as the relationship between supply and demand, frequency of Imbruvica market, the dominant players in the Imbruvica market, the drivers, constraints and challenges. The report also contains market revenues, sales, Imbruvica production and manufacturing costs which could help you
Imbruvica Market 2020 Key Futuristic Trends and Competitive Landscape 2025 | Jan …
Global Imbruvica market would thus note a steady growth over the forecast period of 2020 - 2025. The robust CAGR (Compound Annual Rate Growth) will chart an upward growth curve and create lucrative growth opportunities in the global Imbruvica market. In, turn, this will lead to improvement in market worth. Request a PDF sample of this report: Global Imbruvica Market: Notable Development Global Imbruvica market is set to witness growth and a
Global Imbruvica Market to Witness a Pronounce Growth During 2024– Top Key pla …
Market Research Report Store offers a latest published report on Imbruvica Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Imbruvica players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Imbruvica with respect to individual growth trends, future prospects,
Imbruvica Market Competitive Landscape Outlook to 2023: AbbVie (Pharmacyclics), …
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia. Global “Imbruvica Market” peaks the detailed analysis of industry share, growth factors, development trends, size, majors manufacturers and 2023 forecast. The report also analyze innovative business strategies, value added factors